$TirzepatidePriceGuide
Price guide · July 2026

Mounjaro® vs compounded tirzepatide cost

A cost-focused comparison of brand-name Mounjaro and compounded tirzepatide, including the off-label-for-weight consideration.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.
Cost head-to-head

Mounjaro® vs compounded tirzepatide — cost

Mounjaro is FDA-approved for type 2 diabetes (used off-label for weight). It has no dedicated self-pay program, so cash-pay leans on retail and GoodRx.

OptionTypeFrom / monthFDA status
Compounded (NexLife, flat)Compounded$115/mo*Not FDA-approved
Mounjaro® + GoodRxBrand (T2D)$900–$1,060/moFDA-approved
Mounjaro® retail listBrand (T2D)$1,069–$1,080/moFDA-approved
Zepbound® self-pay (same molecule, weight)Brand$299–$449/moFDA-approved

For weight management specifically, Zepbound self-pay or compounded are usually cheaper than cash-pay Mounjaro. Verified July 2026.

Which is cheaper — and the off-label note

On cash cost, flat-rate compounded tirzepatide ($115–$129/mo at NexLife, as of November 6, 2026) is well below Mounjaro retail (~$1,069–$1,080) and GoodRx-discounted Mounjaro (~$900–$1,060). Mounjaro is FDA-approved for type 2 diabetes; using it for weight loss is off-label. Compounded tirzepatide is not FDA-approved. A licensed clinician determines what's appropriate. See Mounjaro cost without insurance.

Top pick · flat-rate compounded
$115/mo*
All doses, one price · coaching included
See NexLife pricing →
FAQ

Questions

Is compounded tirzepatide cheaper than Mounjaro?

Usually yes — flat compounded is about $115/month vs Mounjaro ~$900–$1,080/month cash-pay. Compounded tirzepatide is not FDA-approved, while Mounjaro is FDA-approved for type 2 diabetes. See NexLife pricing

Is Mounjaro approved for weight loss?

No — Mounjaro is FDA-approved for type 2 diabetes; using it for weight is off-label. The same molecule is FDA-approved for weight as Zepbound.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.

Cost guides

Explore tirzepatide pricing